









Markets
/
Stocks
/
nasdaq-mrna
/

Moderna Inc

MRNA

View Detailed Chart

27.605USD

-1.955-6.61%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

10.74BMarket Cap

LossP/E TTM



Moderna Inc

27.605

-1.955-6.61%

Overview Company Financials

Financials

Intraday

30m

Today

-6.61%

5 Days

-19.17%

1 Month

-9.46%

6 Months

-24.47%

Year to Date

-33.61%

1 Year

-68.12%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 26 analysts

HOLD

Current Rating

45.950

Target Price

66.46%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Moderna Inc

MRNA

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(2)

Buy(0)

Indicators

Sell(2)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.329

Neutral

RSI(14)

36.944

Neutral

STOCH(KDJ)(9,3,3)

16.566

Sell

ATR(14)

1.686

Low Volatility

CCI(14)

-255.024

Oversold

Williams %R

88.474

Oversold

TRIX(12,20)

0.509

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

31.177

Sell

MA10

32.241

Sell

MA20

32.277

Sell

MA50

29.157

Sell

MA100

28.634

Sell

MA200

35.082

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.

Ticker SymbolMRNA

CompanyModerna Inc

CEOMr. Stephane Bancel

Websitehttps://www.modernatx.com/